Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets—“Sand Out and Gold Stays”
- Ying Shao
- , Valeria Chernaya
- , Candice Johnson
- , William Y. Yang
- , Ramon Cueto
- , Xiaojin Sha
- , Yi Zhang
- , Xuebin Qin
- , Jianxin Sun
- , Eric T. Choi
- , Hong Wang
- , Xiao feng Yang
- Temple University
- Thomas Jefferson University
Research output: Contribution to journal › Article › peer-review